Dictionary

allow_url_fopen is ENABLED Dictionary Search

ritonavir

Synonyms

Noun

1. Norvir

2. protease inhibitor, PI

Usage
Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients - The New England Journal of Medicine
A study on the stability of ritonavir form III processed in orbit and returned to Earth | npj Microgravity - Nature
Nirmatrelvir-Ritonavir Speeds COVID-19 Recovery but Fails to Reduce Hospitalizations in Vaccinated High-Risk Adults - Pharmacy Times
Nirmatrelvir-Ritonavir Significantly Lowers Risk for COVID-19-Related Hospitalization - Infectious Disease Advisor
Cost-Effectiveness of Nirmatrelvir-Ritonavir Varies by COVID-19 Risk Profile - AJMC
Nirmatrelvir/ritonavir use reduces risk for long COVID in patients with immunodeficiency - Rockefeller University Press
COVID-19 Treatment Clinical Care for Outpatients - Centers for Disease Control and Prevention | CDC (.gov)
The curious case of disappearing polymorphs - Chemistry World
13 Things To Know About Paxlovid, the COVID-19 Pill | News - Yale Medicine
Paxlovid doesn’t reduce hospitalization, death rates in vaccinated high-risk COVID outpatients, trial shows - CIDRAP
Boceprevir Label Revised: Do Not Coadminister With Ritonavir-Boosted HIV Protease Inhibitors - Gastroenterology & Endoscopy News
Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial - The Lancet
If It's COVID, Paxlovid? Studies Suggest a Rethink These Days - MedPage Today
Predicting the ritonavir crisis by revisiting the polymorph landscape with crystal structure prediction and form 4 structure solution | Communications Chemistry - Nature
Paxlovid speeds recovery but does not reduce severe COVID outcomes in vaccinated adults - News-Medical
Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients - The New England Journal of Medicine
Greater benefits of immediate nirmatrelvir-ritonavir initiation for post-COVID outcomes: a population-based retrospective cohort study - Nature
Effectiveness of nirmatrelvir/ritonavir and molnupiravir in reducing the risk of short-term and long-term cardiovascular complications of COVID-19: a target trial emulation study - Nature
A real-world retrospective analysis comparing the effectiveness of Azvudine and Nirmatrelvir/Ritonavir in COVID-19 patients with diabetes - Nature
Drug-related problems and challenges encountered by pharmacists in nirmatrelvir/ritonavir counselling during the covid-19 pandemic: a multi-center study - Nature
Nirmatrelvir-Ritonavir Has Variable Impact on Incidence of Post-COVID-19 Condition - Pharmacy Times
Based a Machine Learning Approach to Investigate the Factors Influencing Nirmatrelvir/ritonavir Exposure in Human Plasma: A Multicenter, Observational Study - Frontiers
Trials demonstrate Paxlovid’s evolving role against COVID-19 - Healio
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 - The New England Journal of Medicine
Trial data show ensitrelvir has potent antiviral activity against COVID-19 - CIDRAP
Oral Nirmatrelvir–Ritonavir as Postexposure Prophylaxis for Covid-19 - The New England Journal of Medicine
Nirmatrelvir/ritonavir use in pregnant women with SARS-CoV-2 Omicron infection: a target trial emulation - Nature
Profound Synergistic Bradycardia: Pharmacokinetic Consequences of Paxlovid-Mediated CYP3A4 and CYP2D6 Inhibition on Ranolazine, Diltiazem, and Metoprolol - Cureus
VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19 - The New England Journal of Medicine
10 Common Ritonavir Interactions You Want to Watch for - GoodRx
Nirmatrelvir plus ritonavir reduces COVID-19 hospitalization and prevents long COVID in adult outpatients - Nature
Exploring the therapeutic mechanism of itraconazole combined with ritonavir on Candida albicans infection through network pharmacology and molecular docking - Frontiers
Optimal timing of nirmatrelvir/ritonavir treatment after COVID-19 symptom onset or diagnosis: target trial emulation - Nature
Paxlovid for Hemodialysis Patients with COVID-19 - respiratory-therapy.com
Complete Heart Block Triggered by Nirmatrelvir-Ritonavir and Verapamil: - JACC Journals
Microgravity Is The Final Frontier For Medicine. Here's Why. - ScienceAlert
Nirmatrelvir Speeds Recovery, Cuts Symptoms in COVID-19 - Medscape
Paxlovid substantially reduced risk of hospitalization, death during Omicron wave - Hospital News
Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial - The Lancet
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV - Nature
Nirmatrelvir/ritonavir and risk of long COVID symptoms: a retrospective cohort study - Nature
Effectiveness of nirmatrelvir/ritonavir in children and adolescents aged 12–17 years following SARS-CoV-2 Omicron infection: A target trial emulation - Nature
Stability indicating RP-HPLC technique for simultaneous estimation of nirmatrelvir and ritonavir in their new copackaged dosage form for COVID-19 treatment - Nature
Nirmatrelvir–ritonavir versus placebo–ritonavir in individuals with long COVID in the USA (PAX LC): a double-blind, randomised, placebo-controlled, phase 2, decentralised trial - The Lancet
Comparative effectiveness of combination therapy with nirmatrelvir–ritonavir and remdesivir versus monotherapy with remdesivir or nirmatrelvir–ritonavir in patients hospitalised with COVID-19: a target trial emulation study - The Lancet
Effectiveness of nirmatrelvir–ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care system - The Lancet
AustralaSian COVID-19 Trial (ASCOT) removes hydroxychloroquine and lopinavir/ritonavir arms of the trial - Doherty Institute
Efficacy and safety of azvudine versus nirmatrelvir/ritonavir in cancer patients with COVID-19 - Nature
Predictors of nirmatrelvir–ritonavir receipt among COVID-19 patients in a large US health system - Nature
Interferon Beta-1b and Lopinavir–Ritonavir for Middle East Respiratory Syndrome - The New England Journal of Medicine
Rebound of SARS-CoV-2 Infection after Nirmatrelvir–Ritonavir Treatment - The New England Journal of Medicine
Nirmatrelvir–Ritonavir and Viral Load Rebound in Covid-19 - The New England Journal of Medicine
WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19 - World Health Organization (WHO)
Lopinavir–Ritonavir versus Nelfinavir for the Initial Treatment of HIV Infection - The New England Journal of Medicine
Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: a - The Lancet
Norvir (Ritonavir) for HIV: Dosage, Side Effects, and More - TheBody
Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 - The New England Journal of Medicine
Comparison of azvudine, molnupiravir, and nirmatrelvir/ritonavir in adult patients with mild-to-moderate COVID-19: a retrospective cohort study - Nature
Extended nirmatrelvir–ritonavir treatment durations for immunocompromised patients with COVID-19 (EPIC-IC): a placebo-controlled, randomised, double-blind, phase 2 trial - The Lancet
Association of nirmatrelvir–ritonavir with post-acute sequelae and mortality in patients admitted to hospital with COVID-19: a retrospective cohort study - The Lancet
COVID-19 Management With Paxlovid (Nirmatrelvir-Ritonavir) Effective in CKD - Vaccine Advisor
Nirmatrelvir-Ritonavir Shows No Outcome Benefit in Vaccinated High-Risk COVID-19 Patients: NEJM - Medical Dialogues
VV116 or Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19 - The New England Journal of Medicine
Effectiveness and safety of azvudine versus nirmatrelvir-ritonavir in adult patients infected with COVID-19 omicron strains: a retrospective study in Beijing - Nature
Unexpected voriconazole toxicity due to nirmatrelvir/ritonavir: a case report on drug-drug interaction and the role of therapeutic drug monitoring - Frontiers
Risk for Bradycardia in Patients With COVID-19 Treated With Ritonavir - The Cardiology Advisor
Association of Molnupiravir and Nirmatrelvir-Ritonavir with reduced mortality and sepsis in hospitalized omicron patients: a territory-wide study - Nature
Case Report: Nirmatrelvir/Ritonavir and Tacrolimus in a Kidney Transplant Recipient With COVID-19 - American Academy Of Family Physicians | AAFP
Adjusted green HPLC determination of nirmatrelvir and ritonavir in the new FDA approved co-packaged pharmaceutical dosage using supported computational calculations - Nature
Optimizing the use of nirmatrelvir/ritonavir in solid organ transplant recipients with COVID-19: A review of immunosuppressant adjustment strategies - Frontiers
Effects of Ritonavir-Boosted Darunavir vs Doravirine in Patients With HIV Infection - Infectious Disease Advisor
Dolutegravir noninferior to a ritonavir-boosted protease inhibitor regimen for treating HIV - 2 Minute Medicine
Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management - The Lancet
Paxlovid (nirmatrelvir and ritonavir) for the Treatment of Covid-19 - Clinical Trials Arena
Could mechanochemistry have saved Abbott Laboratories $250 million? - Chemistry World
Efficacy and biological safety of lopinavir/ritonavir based anti-retroviral therapy in HIV-1-infected patients: a meta-analysis of randomized controlled trials - Nature
Dolutegravir plus darunavir superior to three-drug darunavir combination in second-line treatment - Aidsmap
Potential pharmacokinetic interactions with concurrent use of herbal medicines and a ritonavir-boosted COVID-19 protease inhibitor in low and middle-income countries - Frontiers
Yes We Can (Use Nirmatrelvir/Ritonavir Even in High Immunological Risk Patients Treated with Immunosuppressive Drugs)! - Springer Nature Link
Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19 - Frontiers
High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment - Nature
Development and validation of a RP-HPLC method for simultaneous determination of five COVID-19 antiviral drugs in pharmaceutical formulations - Nature
Nirmatrelvir/Ritonavir Regimen for Mild/Moderately Severe COVID-19: A Rapid Review With Meta-Analysis and Trial Sequential Analysis - Annals of Family Medicine
Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19 - The New England Journal of Medicine
Targeting the coronavirus SARS-CoV-2: computational insights into the mechanism of action of the protease inhibitors lopinavir, ritonavir and nelfinavir - Nature
Darunavir/ritonavir and raltegravir coadministered in routine clinical practice: Potential role for an unexpected drug interaction - ScienceDirect.com
Darunavir/Ritonavir With Rifampicin May Be Hepatotoxic - Infectious Disease Advisor
Uptick in Paxlovid Shows No Clinical Benefit in Vaccinated Older Adults With COVID-19 - Vaccine Advisor
Nirmatrelvir-Ritonavir Has Little Impact on COVID-19 Hospitalization, Mortality in Vaccinated Older Adults - Pharmacy Times
Real-world effectiveness of nirmatrelvir–ritonavir against BA.4 and BA.5 omicron SARS-CoV-2 variants - The Lancet
Taking PAXLOVID® (nirmatrelvir tablets and ritonavir tablets) from the Lab to Patients to Combat COVID–19 - Pfizer
Simultaneous green TLC determination of nirmatrelvir and ritonavir in the pharmaceutical dosage form and spiked human plasma - Nature
Ritonavir | Podcast - Chemistry World
COVID outpatients don't benefit from hydroxychloroquine, lopinavir-ritonavir - CIDRAP
Pfizer readies its next-generation COVID-19 antiviral - ACS Publications
Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study - The Lancet
Contraindications exist between ritonavir/nirmatrelvir and some CV medications - Healio
VisualAbstract: Oral Nirmatrelvir-Ritonavir Postexposure Prophylaxis Does Not Reduce the Risk of Developing Symptomatic Covid-19 - 2 Minute Medicine
Why does Paxlovid make things taste bitter? - Science | AAAS
Darunavir/Fluticasone-propionate/Ritonavir interaction - Springer Nature Link
Foreign Language Equivalents
Foreign Language Equivalents of 'ritonavir'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
ritonavi,   ritonavirr,   ritonaavir,   ritonavur,   itonavir,   ritpnavir,   ritnoavir,   rtonavir,   ritinavir,   ritonsvir,   ritoanvir,   ritonavor,   ritoavir,   riitonavir,   rionavir,   ritonvair,   rironavir,   irtonavir,   ritonacir,   rtionavir,   rittonavir,   eitonavir,   ritonaivr,   ritonavr,   ritonabir,   rritonavir,   titonavir,   ritomavir,   riyonavir,   ritonaviir,   ritonavvir,   ritonavit,   ritonnavir,   ritnavir,   ritonavri,   ritonavie,   riotnavir,   ritobavir,   ritoonavir,   rutonavir,   rotonavir,   ritonair,   ritonvir
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z